Skip to main content

Table 1 Characteristics of the patients at baseline

From: Effectiveness of tailored screening for multidrug-resistant organisms upon admission to an intensive care unit in the United Arab Emirates

 

Total (N = 2284)

Tested positive* (N = 128)

Tested negative (N = 2156)

P value

Age, median (IQR), years

59.0

(45.0, 72.0)

66.5

(55.0, 76.8)

58.0

(45.0, 71.0)

< 0.001

Female

650 (28.5%)

42 (32.8%)

608 (28.2%)

0.261

Reason for admission

   

< 0.001

Postoperative monitoring

1341 (58.7%)

45 (35.2%)

1296 (60.1%)

 

Acute respiratory failure

386 (16.9%)

43 (33.6%)

343 (15.9%)

 

Sepsis/Septic shock

152 (6.7%)

17 (13.3%)

135 (6.3%)

 

Circulatory failure

96 (4.2%)

9 (7.0%)

87 (4.0%)

 

Neurogenic failure

59 (2.6%)

5 (3.9%)

54 (2.5%)

 

Admitted department

   

< 0.001

Cardiology

1256 (55.0%)

33 (25.8%)

1223 (56.7%)

 

Surgical department

306 (13.4%)

16 (12.5%)

290 (13.5%)

 

Medical department

722 (31.6%)

79 (61.7%)

643 (29.8%)

 

APACHE II score (N = 2082)

9 (6, 15)

16 (9, 23)

9 (6, 15)

< 0.001

MDRO risk factors

    

Admission history

772 (33.8%)

85 (66.4%)

687 (31.9%)

< 0.001

Surgical history

201 (8.8%)

25 (19.5%)

176 (8.2%)

< 0.001

Use of any catheter

365 (16.0%)

64 (50.0%)

301 (14.0%)

< 0.001

Previous antibiotic exposure

486 (21.3%)

71 (55.5%)

415 (19.2%)

< 0.001

Previous MDRO carriage history

65 (2.8%)

26 (20.3%)

39 (1.8%)

< 0.001

Comorbidities

    

Diabetes mellitus

991 (43.4%)

59 (46.1%)

932 (43.2%)

0.525

Myocardial infarction

435 (19.0%)

22 (17.2%)

413 (19.2%)

0.582

Chronic kidney disease

168 (7.4%)

12 (9.4%)

156 (7.2%)

0.368

Stroke

169 (7.4%)

26 (20.3%)

143 (6.6%)

< 0.001

Peripheral vascular disease

56 (2.5%)

11 (8.6%)

45 (2.1%)

< 0.001

Liver disease

38 (1.7%)

9 (7.0%)

29 (1.3%)

< 0.001

Cancer

227 (9.9%)

19 (14.8%)

208 (9.6%)

0.056

  1. Note: IQR = interquartile range, APACHE = acute physiology and chronic health evaluation, MDRO = multidrug-resistant organisms
  2. * Positive for any MDROs (MRSA, CRE, CRAB, and VRE)